Case Study 18: Cirrhosis Skylar Strobel.

Slides:



Advertisements
Similar presentations
Hepatocirrhosis Liver cirrhosis.
Advertisements

Dr. Gehan Mohamed Dr. Abdelaty Shawky
GASTROINTESTINAL Pathology I January 9, Gastrointestinal Pathology I Case 1.
Approach to a patient with jaundice
Prepared by: Tristan Villanueva Arcibal BSN-RN Presented on: July 16, 2013 A CASE PRESENTATION OF A PATIENT WITH DIABETIC KETOACIDOCIS (DKA)
Chronic Liver Disease Simon Lynes. Definition Progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
Nawal Raja Marianne Estrada Angelica Bengochea Period 0
Pancreatitis Acute pancreatitis. Definition Is an inflamation of the pancreas ranging from mild edema to extensive hemorrhage the structure and function.
Case study Mr. Wang, a 64-year-old male, presented with nausea and coffee ground emesis in your department. In the past 1 month, he suffered from recurrent.
Unusual Tanning By Chris Sanders.
Common abdominal syndromes. Gastroesophageal reflux disease - GERD n History: heartburn, chest pain, regurgitation, acidic taste in mouth, dysphagia,
Medical Grand Rounds Clinical Vignette Matthias C. Kugler, M.D. Internal Medicine Resident
LIVER PATHOLOGY LAB MHD II January 20, Case 1 Describe the low power findings.
CDI Education Cirrhosis 4/17/2017.
Benign Prostatic Hyperplasia. BPH  Benign increase in size of prostate  Hyperplasia of stromal and epithelial cells  Nodules.
Cirrhosis of the Liver Kayla Shoaf.
Liver failure.
Liver pathology: CIRRHOSIS
Liver Cirrhosis S. Diana Garcia
Acute Liver Failure. 30 year old woman presents to hospital with a two day history of nausea, vomiting, and right upper quadrant pain. She has been healthy.
HEPATOPANCREATOBILIARY Tom Drake and Fran Young. THE BILIRUBIN CYCLE.
Consequences of Alcohol Use. Basic facts Alcohol is the most widely used and abused drug. Although drinking alcohol is illegal for people under the age.
By: Michelle Russell Case Study Presentation NUR 4216L
Nursing Care of Clients with Gallbladder, Liver and Pancreatic Disorders Chapter 27.
Abdominal and Gastrointestinal Emergencies-3
I n t e g r i t y - S e r v i c e - E x c e l l e n c e Headquarters U.S. Air Force 1 Clinical Assessment of Alcohol Use.
Chapter 9 Diseases of the Gastrointestinal System.
Chronic liver disease Cirrhosis hepatic Encephalopathy Dr. Yasir M Khayyat MBcHB,FRCPC,FACP,ABIM Assistant professor of Medicine Faculty of Medicine Umm.
Hepatitis C -The Long Term Care Risk
JAUNDICE Prepared by: ALIA ZULAIKHA MOHD HANIF D11B037 AHMAD SALLEHUDDIN MUKHTARRUDDIN D11A001 ABDUL MUHAIMIN ABD WAHAB D11A007 AHMAD HANIF B. M AMIN D11B043.
Adult Medical- Surgical Nursing Gastro-intestinal Module: Liver Cirrhosis.
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
JCM OSCE Questions Caritas Medical Centre 3 June, 2015.
NYU Medical Grand Rounds Clinical Vignette Phillip Joseph, MD, PGY-2 September 25 th, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
CASE 102: 48-Year-Old man with nausea and weakness.
Cirrhoses And Its Complications Ahmad Shavakhi.
INCIDENTAL FINDINGS Joel Thompson, MSIII November 19, 2008.
Interventions for Clients with Liver Cancer. Cancer of the Liver One of the most common tumors in the world Most common complaint: abdominal discomfort.
Clinical round By Dr. Ehab M. Oraby
C IRRHOSIS. A LCOHOLIC L IVER I NJURY : Alcoholic Liver disease - Patterns Fatty change, Acute hepatitis Chronic hepatitis Cirrhosis, Chronic Liver failure.
CIRRHOSIS.
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
GASTROINTESTINAL PATHOLOGY LAB #1 January 10, 2013.
EFFECTS OF ALCOHOL. Target: I will be able to identify the dangers associated with using alcohol and the describe short/long term effect of use Pg.
Hepatitis C.
Cirrhoses And Its Complications Ahmad Shavakhi.MD Associate professor of gastroenterology.
Digestive System Disorders By Adrienne, Lacey, and Lindsey.
Steve Bradley Chief Medical Resident, HMC Inpatient Services.
우연히 발견된 폐결절환자 증례 호흡기내과 R1 최윤영/ Prof. 박명재
Thorax and Abdomen Injuries. Injuries to the Lungs MOI Pneumothorax Pleural cavity surrounding the lung becomes filled with air that enters through a.
Soonchunhyang University Chonan Hospital G-I Department 순천향 대학교 천안 병원 소화기내과 이재학, 이석호, 김현준, 정일권, 박상흠, 김선주 CASE PRESENTATION.
Polygrandular Autoimmune Syndrome 내분비대사 내과 R1 권성진.
Intern Report Patient Presentation  55yM no PMH presenting with worsening abdominal pain for 2-3 days. Describes pain as diffuse, non-radiation,
Recurrent hepatitis with Halogenated Anesthetics
25 y old patient presented with history of heart burn & regurgitation ( especially on bending ) >2 times/week for the last 6 months. Examination was unremarkable.
Chapter 2 Diseases of the Abdomen
Case presentation 경희의료원 내과 R2 조창현.
Liver and Biliary Tract Disease
Qassim J. odda Master in adult nursing
ACUTE LIVER FAILURE Acute liver failure is defined as the rapid development of hepatocellular dysfunction (WITHIN 8 WEEKS OF DISEASE ONSET), specifically.
CIRRHOSIS LIVER Alanoud Aldrsony.
Successful TACE for HCC
DIAGNOSIS OF CIRRHOSIS
AFP > 9000 without demonstrable HCC
Emphysema Lung Cancer Cirrhosis
CLINICAL SOLVING PROBLEM
Presentation transcript:

Case Study 18: Cirrhosis Skylar Strobel

Overview Role of liver Scar tissue forms as liver repairs itself Wide range of causes Liver plays a role in digestion through the production of bile, detoxifies chemicals, metabolizes drugs and makes proteins

Patient S.G. 46 yo white male History of chronic alcoholism Abdominal swelling and confusion Gained 15 lbs Lethargic, acting strangely

PMH Cirrhosis, 4 years ago H/O: Father died at age 52 Uncontrolled ascites and peripheral edema Anemia Acute pancreatitis E. coli-induced bacterial peritonitis Father died at age 52 H/O alcohol abuse H/O IVDA and intranasal cocaine ½ ppd for many years Ascites-build of fluid in the lining between the abdomen and abdominal organs

Review of Systems Increasing abdominal girth No complaints of abdominal pain, fever, chills, nausea, hematemesis, tarry stools, cough, chest pain, weakness, blood in urine, diarrhea or dry mouth

Patient Case Question 1: Hematemesis and tarry stools are clinical signs of which serious potential complication of cirrhosis? Hematemesis = vomiting of blood Acute gastrointestinal bleeding

Physical Exam Skin HEENT Chest Abdomen Genit/Rect Neuro Mild jaundice (+) spider nevi on chest (-) palmar erythema Several ecchymoses on lower extremities HEENT (+) icteric sclera Chest (+) gynecomastia Abdomen Moderately distended, firm, slightly tender (+) prominent veins (+) HSM Genit/Rect Testicles atrophied (+) hemorrhoids Neuro Confused, disoriented

Patient Case Question 2: Identify 15 clinical signs and symptoms consistent with a diagnosis of cirrhosis

Unusual violent behavior Skin Weight gain Lethargy Confusion Unusual violent behavior Skin Mild jaundice (+) spider nevi on chest Several ecchymoses on lower extremities HEENT (+) icteric sclera Chest (+) gynecomastia Abdomen Moderately distended, firm, slightly tender (+) prominent veins (+) HSM Genit/Rect Testicles atrophied (+) hemorrhoids Neuro Confused, disoriented

Lab Test Results Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL

3. Anemic? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Look at hemoglobin, hematocrit, MCV, platelets and WBC Then look at iron in the blood

4. Abnormality of CBC? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Super low platelet count – lower range is around 150,000

5. Sudden progression? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL

6. Four risk factors Alcohol Abuse Hepatitis C Overweight Liver Cancer Anti-HCV test + Overweight Height: 5’7” Weight: 171 lbs BMI = 26.8  overweight Liver Cancer AFP test – 90 ng/mL Normal – 0-15 ng/mL

7. Bacterial peritonitis? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL To diagnose: high WBC, protein greater than 1g/dL, glucose less than 50 mg/dL

8. Why do an ANA test? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL ANA-antinuclear antibodies, may help find autoimmune chronic hepatitis, could cause cirrhosis

9. Hemochromatosis? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (+) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Means there is too much iron in the body, iron overload, all are WNL

10. Wilson’s disease? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Inherited, too much copper in body’s tissues, normal limits

11. Why can autoimmune hepatitis and primary biliary cirrhosis be ruled out as contributing factors to this patient’s condition? Because both are autoimmune disorders but the ANA was normal

Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Both are autoimmune dieases, but tested negative for ANAs

12. Osteoporosis? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL

13. Evidence for ascites Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Alb low, protein high – indicative of the presence of ascites

14. Hepatic encephalopathy? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Worsening of brain function that occurs when liver is no longer able to remove toxic substances in the blood, primary indicator is ammonia Nh3 VERY high, 18-60ug/dL

15. Grade this encephalopathy? 0: Minimal HE Hard to detect, changes in memory, concentration and temper are minimal 1: Mild HE Short attention span, noticeable mood changes, sleep problems 2: Moderate HE Forgetfulness worsens, lethargic, exhibit inappropriate behavior, slurred speech, and difficulty with mental tasks 3: Severe HE Confused as to where you are or what day it is, extremely sleepy, unable to do basic mental tasks, extremely anxious, act strangely 4: Coma Unconscious, slip into coma

16. Patient’s CTP score? Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Child-Pugh Score used to assess prognosis of chronic liver disease, mainly cirrhosis, look at these lab rseults, then grade ascites and encephatholgy grade to obtain the score (online calculator) Score = 12, Class C, life expectancy of 1-3 years

17. One year survival? Based on his class C CTP score, this patient has a 45% probability of surviving another year

18. Does the patient have any signs of dehydration or hepatorenal syndrome?

Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL Dehydration look at electrolytes, and hepatorenal syndrome = rapid deterioration in kidney function inidividuals with cirrhosis, look at BUN and Cr

19. The patient’s primary care provider has decided to conduct extensive clinical studies for the diagnosis of liver cancer. Which single abnormal laboratory value has raised a concern that hepatocellular carcinoma may have developed?

Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Na 135 meq/L WBC 4700/mm3 Mg 1.7 mg/dL K 3.5 meq/L PT 15.6 sec AFP 90 ng/mL Cl 101 meq/L PTT 45.1 sec HBsAg (-) HCO3 25 meq/L NH3 250µg/dL HIV (-) BUN 12 mg/dL AST 107 IU/L Anti-HCV (-) Cr .6 mg/dL ALT 86 IU/L HCV RNA 2.8 million/mL Glu 90 mg/dL Alk phos 224 IU/L ANA (-) Hb 14.0 g/dL Bilirubin 2.4 mg/dL Fe 75 µg/dL Hct 39.7% Protein 6.6 g/dL Ferratin 200 ng/mL MCV 90 fL Alb 2.7 g/dL Transferrin saturation 38% Plt 34500/mm3 Ca 8.5 mg/dL Ceruplasmin 37 mg/dL AFP-alpha-fetoprotein, tumor marker, helps in the diagnosis of liver cancers